Workshop A

Enhancing the Translatability of Immuno-Oncology Therapeutics


9:00am – 12:00pm

An unprecedented range of immuno-oncology combination approaches are currently under investigation, but without robust preclinical validation backing the mechanism of action of these strategies, many of these studies will fail to reach their clear potential. This interactive workshop will share how the efficacy of immuno-oncology agents can be investigated in translational culture systems, providing you with the valuable tools to enhance your immuno-oncology work.

Attend this workshop to gain valuable insights into:

  • A novel ex vivo human system to investigate immuno-oncology agents
  • A novel ex vivo human system to investigate immuno-oncology agents
  • Insights into the mechanistic data that can be generated from translational systems and how this can enhance immuno-oncology clinical development


Prasad Adusumilli
Deputy Chief and Attending (Tenured), Thoracic Surgery; Director, Mesothelioma Program, Head, Solid Tumors Cell Therapy, Cellular Therapeutics Center (CTC)
Memorial Sloan-Kettering Cancer Center


Navin Chintala
Research Assistant
Memorial Sloan-Kettering Cancer Center

Workshop B

Innovative Discovery and Delivery Approaches for Bispecifics for Infectious Disease Indications

1:00pm – 4:00pm

Developing bispecifics for infectious diseases is challenging, but the potential rewards for success are huge, given the global unmet need in many of these indications. An increasing amount of bispecific development is taking place outside oncology, using new enabling technologies to tackle the complex challenges inherent to infectious diseases applications is critical to success.

Attend this workshop to gain valuable insights into:

  • Case studies outlining protein engineering innovations to develop and adapt formats to complex biological contexts
  • Investigating new gene-encoded methods for in vivo delivery using non-viral synthetic DNA to enable to body to produce bispecifics
  • Understanding the flexibility and range of different bispecific designs able to be delivered using this approach
  • The future promise of bispecifics in addressing unmet medical need in the infectious disease space


Jonathan Lai
Professor, Biochemistry
Albert Einstein College of Medicine



Ami Patel
Wistar Institute